433PAn open-label, phase I, dose escalating study evaluating safety, tolerability and pharmacokinetics of oral administration of irinotecan in adult patients with solid tumors
Palshof, J A, Kümler, I, Sørensen, P G, Jensen, B V, Nielsen, D LVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy279.420
Date:
October, 2018
File:
PDF, 81 KB
english, 2018